Entegris Bolstered Operational Response to COVID-19
We are playing a supporting but crucial role in our customers’ efforts to develop and manufacture therapies for COVID-19 and are currently undergoing rapid scale up to meet commercial demand for the pipeline of potential successful candidates. You can be certain that we are committed to remaining a strong partner and as such, have dedicated ourselves to maintaining critical operations by relying on our business continuity plans and leveraging trusted supply partners.
|
Please submit this form if you would like additional detailed program information about Entegris’ COVID-19 programs for maintaining critical operations and accessibility or more about our participation in the BioPhorum and Rx-360 Joint Audit Model and enhanced Aramus 2D bag assembly validation guide improvements.
We are committed to helping you solve your most critical process challenges; you can be certain we will continue taking proactive steps to be a secure and reliable partner.
